Trial Profile
Montelukast, on pediatric bronchial asthma in multicenter comparative double-blind clinical study (phase IV) with ketotifen fumarate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Ketotifen
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck & Co; Organon
- 03 May 2007 New trial record.